Tesamorelin is not appropriate for patients with active malignancy, uncontrolled diabetes, proliferative retinopathy, or during pregnancy or breastfeeding
1 Stay focused on health Connect wellness with GLP-1 therapy Learn how you can support your GLP-1 patients
Monitoring blood glucose, thyroid function, IGF-1 levels, and clinical symptoms becomes essential
It's all checkbox medicine
Across multiple trials, tirzepatide outperformed every comparator, including semaglutide at its highest dose
Carruthers, 2017) show no cumulative toxicity over a decade of treatment, no measurable atrophy of treated muscle beyond what reverses on discontinuation, and stable result reproducibility across product brands